Bu çalışmada, literatürde yapılan piridindikarboksilik asit türevleri {2,3-piridindikarboksilik asit, 2,3-piridindikarboksilik asit n-oksit, 3,4-piridindikarboksilik asit, 3,5-piridindikarboksilik asit, 5-etil-2,3-piridindikarboksilik asitin, 2,4-piridindikarboksilik asit, 6-metil-2,4-piridindikarboksilik asit N-oksit, 2,5-piridindikarboksilik asit, 2,6-piridindikarboksilik asit, 4-hidroksi-2,6-piridindikarboksilik asit, 2,6-piridindikarboksilik asit N-oksit, 2,3,5-piridintrikarboksilik asit, 6-metil-2,3,5-piridintrikarboksilik asit, 2,4,6-piridintrikarboksilik asit, 2,3,5,6-piridintetrakarboksilik asit, 2,2’-bipiridin-3,3’,6,6’-piridintetrakarboksilik asit, 4,4’-bipiridin-2,2’,6,6’-piridintetrakarboksilik asit} ile bipiridin türevlerinin {2,2′-ditiyodipiridin, 4,4’-bipiridin, 4,4′-ditiyodipiridin, 1,2-bis(4-piridil)etan, 1,2-bis(piridin-4-il)eten, 1,2-bis(4-piridil)etilen, 1,3-di(4-piridil)propan, 1,2-bis(2,4-piridil)etan, 1,2,3,4-tetrakis(4-piridil)bütan, 4,4'-bipiridin N,N-dioksit, bis{2-(piridin-4-il)etenil}benzene, 4,4'-dipiridil-N,N'-dioksit, 1,2,4,5-tetrakis(4-piridil)benzene ve bis(4-piridil)amin} bazı metallerle {La(III), Mn(II), Co(II), Ni(II), Cu(I), Cu(II), Zn(II), Cd(II), Ag(I) Ru(II), In(III), Sn(II), Ga(III), La(III), Ce(III), Sm(III), Tb(III), Dy(III), Ho(III)} karışık ligandlı kompleksleri ve biyolojik aktiviteleri incelenmiştir. Literatürde piridindikarboksilik asit ve bipiridin türevlerinin anti oksidan, anti fungal, anti mikrobiyal, anti tümor, anti kanser, anti inflamatuar, anti ülser, anti diyabetik, analjezik ve radyoprotektif aktivite gibi biyolojik aktiviteleri vardır. Bu iki aktif grubun gösterdiği biyolojik özellikler, bunlardan elde edilecek olan proton transfer tuzu ve metal kompleksleri de benzer özelikler göstereceği aşikardır. Ancak metal kompleklserin aktivite çalışmaları oldukça azdır. Metal komplekslerinin biyolojik özelliklerin daha ayrıntılı bir şekilde çalışılması literature önemli bir katkı olacaktır.
In this study, complexes and biological activities of pyridindicarboxylic acid derivatives {2,3-pyridinedicarboxylic acid, 2,3-pyridinedicarboxylic acid n-oxide, 3,4-pyridinedicarboxylic acid, 3,5-pyridinedicarboxylic acid, 5-ethyl-2,3-pyridinedicarboxylic acid, 2,4-pyridinedicarboxylic acid, 6 -methyl-2,4-pyridinedicarboxylic acid N-oxide, 2,5-pyridinedicarboxylic acid, 2,6-pyridinedicarboxylic acid, 4-hydroxy-2,6-pyridinedicarboxylic acid, 2,6-pyridinedicarboxylic acid N-oxide, 2, 3,5-pyridinetricarboxylic acid, 6-methyl-2,3,5-pyridinetricarboxylic acid, 2,4,6-pyridinetricarboxylic acid, 2,3,5,6-pyridinetetracarboxylic acid, 2,2'-bipyridine-3,3 ', 6,6'-pyridinetetracarboxylic acid, 4,4'-bipyridine-2,2', 6,6'-pyridinetetracarboxylic acid} and bipyridine derivatives {2,2′-ditiyodipiridin, 4,4’-bipiridin, 4,4′-ditiyodipiridin, 1,2-bis(4-piridil)etan, 1,2-bis(piridin-4-il)eten, 1,2-bis(4-piridil)etilen, 1,3-di(4-piridil)propan, 1,2-bis(2,4-piridil)etan, 1,2,3,4-tetrakis(4-piridil)bütan, 4,4'-bipiridin N,N-dioksit, bis{2-(piridin-4-il)etenil}benzene, 4,4'-dipiridil-N,N'-dioksit, 1,2,4,5-tetrakis(4-piridil)benzene ve bis(4-piridil)amin} with mixed ligands with some metals {La(III), Mn(II), Co(II), Ni(II), Cu(I), Cu(II), Zn(II), Cd(II), Ag(I) Ru(II), In(III), Sn(II), Ga(III), La(III), Ce(III), Sm(III), Tb(III), Dy(III), Ho(III)} were investigated. In the literature, pyridindicarboxylic acid and bipyridine derivatives have biological activities such as anti oxidant, anti fungal, anti microbial, anti tumor, anti cancer, anti inflammatory, anti ulcer, anti diabetic, analgesic and radioprotective activity. It is obvious that the biological properties of these two active groups, the proton transfer salt and metal complexes obtained from them will also show similar properties. However, activity studies of metal complexes are very few. A more detailed study of the biological properties of metal complexes will be an important contribution to the literature.
Primary Language | Turkish |
---|---|
Journal Section | Reviews |
Authors | |
Publication Date | June 30, 2021 |
Submission Date | June 2, 2021 |
Published in Issue | Year 2021 Issue: 003 |